Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1998;12(5):320-4.
doi: 10.1002/(sici)1098-2825(1998)12:5<320::aid-jcla13>3.0.co;2-x.

Evaluation of a line immunoblot assay for detection of antibodies recognizing extractable nuclear antigens

H E Prince  1 , W R Hogrefe
Affiliations
Comparative Study

Evaluation of a line immunoblot assay for detection of antibodies recognizing extractable nuclear antigens

H E Prince et al. J Clin Lab Anal. 1998.

Abstract

Sera (n = 90) giving positive results in a screening test for antibodies to extractable nuclear antigens (ENAs) were tested in a line immunoblot assay that measures antibody reactivity with individual ENAs in a single test field. Results were then compared to those obtained in monospecific ENA antibody enzyme immunoassays (EIAs). Discordant results were resolved by immunodiffusion. Of 540 result pairs (90 sera tested for 6 ENAs [Sm/RNP, Sm, SSA, SSB, Scl-70, Jo-1]), 509 (94%) showed concordance. Immunodiffusion resolved 28 of 31 discordant result pairs in favor of the immunoblot result. After resolution of discordant data, the immunoblot assay exhibited 100% sensitivity for all ENA antibodies except those recognizing Scl-70, for which the sensitivity was 89%; specificity was over 96% for all 6 ENA antibodies. These findings show that a line immunoblot assay for the characterization of ENA antibodies yields results comparable to those obtained using monospecific ENA antibody EIAs. The immunoblot assay is easier and less expensive to perform due to its utilization of a single test field.

PubMed Disclaimer

References

    1. Moore TL, Weiss TD, Neucks SH, Baldassare AR, Zuckner J: Extractable nuclear antigens. Semin Arth Rheum 10: 309–318, 1981. - PubMed
    1. Tan EM: Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44: 93–151, 1989. - PubMed
    1. Sharp GC, Irvin WS, May CM, et al.: Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective‐tissue disease, systemic lupus erythematosus, and other rheumatic diseases. N Engl J Med 295: 1149–1154, 1976. - PubMed
    1. Hietarenta M, Lassila O: Clinical significance of antinuclear antibodies in systemic rheumatic diseases. Ann Med 28: 283–291, 1996. - PubMed
    1. McCarthy GA: Autoantibodies and their relation to rheumatic diseases. Med Clin N Am 70: 237–261, 1986. - PubMed

Publication types